Brief: Forward Pharma obtains shareholder approval of capital reduction

Forward Pharma A/S

02/08/2017 21:45

Aug 2 (Reuters) - Forward Pharma A/S  FWP.O  
    * Forward Pharma obtains shareholder approval of the planned 
capital reduction at the extraordinary general meeting 
    * Forward Pharma A/S - got ruling from Danish tax 
authorities covering holders of ordinary shares and holders of 
Forward's American depositary shares 
    * Forward Pharma A/S - based on ruling, company will not be 
withholding any part of proceeds from capital reduction for 
Danish tax 
    * Forward Pharma A/S - majority of votes cast at 
shareholder meeting approved plans to return EUR 917.7 million 
to shareholders through a capital reduction 
 
Source text for Eikon:  ID:nGNXOCUIFa  
Further company coverage:  FWP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))